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Low rectal cancerAbstract Introduction: Abdomino-perineal resection has been the standard treatment for rectal
tumors located 65 cm from the anal verge. Recently, intersphincteric resection became a valid
option which preserves the bowel continuity with better functional outcome.
Aim: Is to evaluate the oncological and functional outcome alongside the associated surgical mor-
bidity in patients with T1-3 rectal cancer, who underwent intersphincteric resection (ISR).
Patients & methods: Between the years 2006 and 2011, 55 patients with invasive rectal adenocarci-
noma, T1-3 lesions, located 2–5 cm from the anal verge underwent ISR with total mesorectal exci-
sion. When inevitable, complete. ISR was performed, otherwise partial ISR was done. All T3
patients underwent total meso-rectal excision (TME) while some had lateral lymph node dissection
(LND) with concomitant pelvic autonomic nerve preservation (PANP).
Results: Among the 55 patients, 21 (38.1%) patients were T1-2 and 34 (61.9%) patients were T3.
The tumor location range was 0–5 cm from the anal verge (median 2.3 cm). Partial or complete ISREgypt.
88 W. Abdel-Gawad et al.was done for 35 (63.6%) and 20 (36.4%), respectively. Patients were followed for a median of
1.5 years (range 1–4.6 years). The 3 year local recurrence and distant metastasis free rates were
85.2% and 85.6%, respectively. All the 3 local recurrences occurred in T3 patients group, and
had positive circumferential resection margins. Overall 3-year disease-free survival was 82.6%;
while the overall 3-year survival was 88.7%.
Conclusion: Intersphincteric resection with TME does not affect the local recurrence or overall
survival rate in early rectal cancer T1-2 & 3, with preservation of bowel continuity and better life
quality.
ª 2014 Production and hosting by Elsevier B.V. on behalf of National Cancer Institute, Cairo University.
Open access under CC BY-NC-ND license.Introduction
The Standard surgical treatment for massively invasive rectal
adenocarcinoma located within 5 cm from the anal verge is
abdomino-perineal resection (APR) [1]. This is because the
length of the anal canal is 3–5 cm [2]. The achieved progress
in current technology, chemotherapy and radiotherapy, com-
bined with a better understanding of the microscopic periphe-
ral invasion of the tumor (the limit should not exceeding
10–15 mm), have now led to the planning and application of
alternative policies of surgical treatment [3–5].
The intersphincteric resection (ISR), ﬁrst proposed by
Schiessel in 1994 for more distal location, combines rectal re-
moval with excision part or whole of the inner sphincter and
restoration by hand sewn colo-anal anastomosis [6]. Generally
the maximum limit, under which this method can be applied,
must be set in the distance of 3 cm from the dentate line.
The superior location of the tumor beyond this limit indicates
low anterior resection and stapled anastomosis, while the low-
er location emerges the choice of intersphincteric resection
[6–8]. With this later, which involves dividing the rectum
between the internal sphincter and the external sphincter or
the levator ani muscles, raised the question of whether a secure
circumferential resection margin (CRM) of the tumor can be
obtained, with the potential risk of increasing recurrence, espe-
cially local recurrence [9–13]. Given the microscopic invasion
of 10–15 mm from the macroscopic limit of the tumor, a free
resection margin must be preserved, without malignant cell
inﬁltration in this distance. So based on this principle, this
method is indicated for tumors located at a distance of
1.5–3 cm from the dentate line, although some set the most
extreme limit for lower location even up to 0.5 cm. The inﬁltra-
tion of the outer sphincter or pelvic ﬂoor muscles is an abso-
lute contraindication for the method [6–8]. ISR is nowadays
being increasingly recognized to achieve a safe distal resection
margin, which can be as small as 1–2 cm [14,15].
Aim
The principal aim of this study is to evaluate the oncological
and functional outcome as well as the associated mortality in
addition to short and long term morbidity in patients with
T1-2 & T3 rectal cancer, who underwent intersphincteric resec-
tion (ISR).
Patients & methods
Between the years 2006 and 2011, a total of 55 consecutive
patients presenting to the outpatient department, fulﬁllingthe inclusion criteria, namely: invasive rectal adenocarcinoma,
T1-3 lesions, and located from 2 to 5 cm from the anal verge.
Patients were recruited from 2006, for the following
36 months, and then were followed-up thereafter till the end
of 2011. Intersphincteric rectal resection (ISR) with total mes-
orectal excision (TME) was performed for all patients at the
National Cancer Institute (NCI), Cairo University.
All patients underwent routine full laboratory blood tests
including base line Carcino-Emberyonic Antigen (CEA), digi-
tal rectal examination (DRE), diagnostic biopsy under local
anesthesia for pathological examination prior to surgery and
full Colonoscopy. Additional routine imaging procedures for
local, regional and distant staging were performed. These in-
cluded: Transrectal ultrasonography (TRUS), chest CT, and
abdominopelvic thin-section MRI with a phased-array coil.
PET-CT was carried out in selected cases with equivocal met-
astatic results.
Selection criteria for ISR were sufﬁcient medical ﬁtness;
normal sphincter function; distance between the tumor and
the anorectal junction (upper edge of the surgical anal canal)
of less than 2 cm; no involvement of the external sphincter;
and no signs of disseminated disease. Patients having T3, T4,
and N positive rectal cancer, received neoadjuvant treatment
for down staging and increasing of the possibility of sphinc-
ter-saving surgery. Lateral node dissection (LND) with con-
comitant pelvic autonomic nerve preservation (PANP) was
carried out in patients with extra-mesorectal lateral nodes de-
tected by MRI if the node diameter is >5 mm in its longest
diameter. Surgery was performed within 6 weeks after neoad-
juvant therapy completion. Written informed consent was ob-
tained from all patients. The functional outcome was assessed
according to Kirwan scale for continence.Surgical technique
ISR and colo-anal anastomosis were performed through a
combined abdominal and perineal approach (Fig. 1). The
abdominal part of the operation was performed using either
the open or the laparoscopic technique.
First, the abdominal part began by a high ligation of the
inferior mesenteric artery to mobilize the left colon, including
taking down the splenic ﬂexure. Total mesorectal excision,
with sharp dissection along an embryologic plane between
the mesorectal and the pelvic sidewall fasciae, while preserving
the hypogastric plexus of nerves, was carried up, following
Heald description [16]. Distal dissection exposed the puborec-
tal muscle, surrounding lateral and posterior rectal walls, at
the pelvic ﬂoor, facilitating the perineal part of the dissection.
This latter began by a good exposition of the anal canal via
Figure 3 ISR with subtotal excision of the internal sphincter for
ultra-low rectal tumor at the ano-rectal junction.
Figure 4 The gap following ISR for ultra-low rectal tumor with
proximal colonic end pulled to anal end.
Figure 1 The dissection lines for the combined abdominal and
per anal approach of intersphincteric resection.
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ical Products Inc., Houston, TX, USA). Diluted epinephrine
(1:20 ml) with saline solution was locally injected, minimizing
bleeding and facilitating intersphincteric dissection. The muco-
sa and internal sphincter were circumferentially incised at least
1 cm distal to the tumor edge. The anal oriﬁce was then closed
trans-anally with purse-string sutures to prevent tumor cell dis-
semination during the procedure.
Three types of ISR were used, namely: total, subtotal, and
partial. When inevitable, due to tumor spread beyond the den-
tate line, total ISR was completed by fully excising the internal
sphincter, so that the distalmargin of the resection is at the inter-
sphincteric groove. In few cases, where the distal edge of the tu-
mor wasmore than 2 cm far from dentate line, subtotal ISRwas
performed, getting the distal resection margin between the den-
tate line and the intersphincteric groove (Fig. 2). Preferably,
when otherwise enough distal surgical margin existed, distal
resection was performed, at or above, the dentate line, named
partial ISR. The limits of the 3 types of ISR are shown in
(Fig. 3). Dissection was continued through intersphincteric
plane up to reach the abdomen dissection level.
Lateral lymph node dissection (LND) and pelvic autonomic
nerve preservation (PANP) were carried out in persisting T3
patients whom MRI pelvic examination revealed nodal diam-
eter >5 mm with heterogeneous pattern. Following rectum
dissection from prostate or vagina, the specimen was removed
per anally (Fig. 4). Frozen-section examination was used to
conﬁrm the lack of tumor cells in the distal margin. A J-pouchFigure 2 Type of ISR according to amount of excision of the
internal anal sphincter. (a) Partial ISR; (b) Subtotal ISR; (c) Total
ISR (Cipe et al. 2012).was done in patients with early tumors at a maximum of 6 cm
from anal verge, while straight colo-anal hand-sewn anasto-
mosis was done to the other patients (Fig. 5). Pelvic drain
was placed, and de-functioning stoma was done for all preop-
eratively irradiated patients and in those with very low tumors.
Postoperative management
Postoperatively, chemotherapy and/or radiotherapy were of-
fered to all indicated patients. All T3 patients received either
neoadjuvant or adjuvant chemoradiation. Patients wereFigure 5 Colo-anal anastomosis for bowel continuity following
ISR for ultra-low rectal tumor.
Figure 7 PET-CT showing sacral recurrence (arrow) following
ISR.
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were reviewed every 3 months for clinical examination, CEA.
Abdomino-pelvic US and CXR were done every 6 months.
CT chest, and abdomino-pelvic MRI with full colonoscopy
were carried out on annual basis. PET-CT was done to
investigate any suspicious ﬁndings during the regular follow-
up protocol. The following 3 years, patients were checked
every 6 months then annually thereafter.
Statistical methods
Data management and analysis were performed using Statisti-
cal Package for Social Sciences (SPSS) vs. 17. Overall survival
and Disease Free Survival times were estimated using the
methods of Kaplan and Meier. Differences between survival
curves were assessed for statistical signiﬁcance with the
log-rank test. All p-values are two-sided. p-values <0.05 were
considered signiﬁcant.
Results
Among the 55 patients included in the study, 21 (38.1%) patients
were T1-2 and 34 (61.9%) patients were T3. The tumor location
range was 0–5 cm from the anal verge (median 2.3 cm). Partial
ISR was done for 35 (63.6%) patients while complete ISR and
external sphincter resection was performed for 20 (36.4%) pa-
tients. Lateral node dissection and Pelvic Nerve Preservation
(PANP) were carried out in only 8 (14.5%) T3 patients with
lateral nodes >5 mm in diameter, as detected by pelvic MRI.
J-pouch was done for 3 (5.4%) patients and covering stoma in
15 (27.3%) patients. Twenty-ﬁve patients with T3 received long
course of neoadjuvant chemo-radiotherapy (CRT), while 9
others with T3 tumors received adjuvant CRT.
Mortality & morbidity
Surgical morbidity occurred in 14/55 patients (25.5%). Early
surgical complications occurred in 12/14 patients (85.7%), in
the form of intestinal obstruction (4 patients, 33.3%), urinary
tract infection (4 patients, 33.3%), respiratory infection (4 pa-
tient, 33.3%), anastomotic leakage (4 patients, 33.3%), and
pelvic sepsis (1 patient). Eight (66.6%) patients were managed
conservatively, among whom 3 patients with anastomotic
leakage had diverting colostomy and drainage, while the
fourth patient, who underwent delayed drainage, developed
massive pelvic sepsis and passed away, to be the study soleFigure 6 CT (A) and MRI (B) pelvis showing lamortality. Delayed surgical morbidity occurred in 2/14
(14.3%) patients including one patient with stomal prolapse,
and another with anastomotic stenosis; both were managed
conservatively.
Oncologic outcome
Patients were followed for a median of 1.5 years (range 1–
4.6 years). All the 3 local recurrences occurred in T3 patient
group; two occurred at the lateral nodal groups; one at the
obturator and the other at the common and internal iliac
lymph node groups (Fig. 6) who underwent adjuvant chemo-
Radiation, one was a sacral recurrence (Fig. 7), who under-
went composite sacral resection (Partial sacrectomy below S3
and APR) while all the 3 patients had positive circumferential
resection margins (CRM) at the primary resection.
The distant disease occurred in 7 patients; one in T2 patient
and the others in T3 patients. In one patient, liver metastasis
was discovered during primary resection, when it underwent
complete non-anatomical resection, while in the other 5 pa-
tients, liver metastasis appeared during the follow-up period.
All the distant recurrences occurred in the T3 patient group,
where 2 patients had liver metastasis, 2 patients developed lung
metastasis, and only one patient harbored metastatic deposits
in both organs. All the patients with distant recurrences re-
ceived primary chemotherapy followed by resection. One pa-
tient with liver metastasis underwent Ablative Radio
Frequency (ARF). Thereby, the 3 year local recurrence and
distant metastasis free rates were 85.2% and 85.6% respec-
tively. The overall 3-year survival was 88.7% (Fig. 8), while
the overall 3-year disease-free survival was 82.6% (Fig. 9).teral nodal recurrence (arrow) following ISR.
Figure 8 Three-years overall survival time.
Figure 9 Three-years Disease Free Survival (DFS) time.
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As per continence, it was subjectively assessed according to
kirwan scale, forty seven patients (85%) were classiﬁed as
Kirwan scale I, and ﬁve patients (10%) were scale II, while
the remaining three patients (5%) were scale III requiring
temporary pads.
Discussion
In this study, overall postoperative complication rate was
25.5% conformal to the reported in the different series from
5.6% to 64% [17–19]. Common complications included leak-
age, anastomotic stricture, ﬁstula, pelvic sepsis, and prolapse.
Anastomotic leakage is the most serious complication since it
has been found to lead to severe sepsis followed by death or
postoperative anastomotic stricture [20] and poor postopera-
tive anorectal function [21]. In this study we reported 33.3%
leakage, much higher when compared to the literature anasto-
motic leakage rates of 0.9–24% [22–24], which varied depend-
ing on whether asymptomatic leaks were radiologically
detected. This high percentage might be explained by the ad-
verse effect of neo-adjuvant chemo-radiation and the early
phase of the learning curve.
Also, different studies reported an anastomotic stricture
rate ranging from 5.8% to 12% [7,13,17,19,20,25]; compara-
tively we reported a similar rate of 8.5% in the current series.
Postoperative intestinal obstruction, reported to be 33% in thisstudy, presented between 0% and 16% [15,26] according to
other various studies, and usually patients, as in our case, re-
sponded to conservative treatment.
We reported a single postoperative mortality from a de-
layed drainage of a resultant pelvic sepsis following intestinal
leakage, compared to most publications who reported a mor-
tality between 0% and 6% for this procedure [7,13,19,20,26].
Thereby, early drainage of pelvis sepsis should always be done
to save the patient life.
From an oncological point of view, local control of the dis-
ease remains the most important objective in rectal cancer sur-
gery. This study showed that invasion through the muscularis
propria (T3) and positive microscopic circumferential resection
margin (CRM) were signiﬁcantly associated with 5.4% local
recurrence rate after ISR, which confers with other authors
results who reported a local recurrence rate of 0–13.3% for
positive CRM [8,13,19,27–33].
For patients with T1-2 lesions, no recurrences have been
diagnosed, though these patients did not receive radiotherapy,
neither before nor after surgery. This matches with other
authors ﬁndings [6,19,34]. Although long-term preoperative
radiotherapy is known to reduce tumor volume and change
protruding tumors into ulcerative scars, facilitating operations
and decreasing tumor spillage, radiotherapy, in both short and
long courses, has the potential to cause damage to both
anorectal and sexual functions. Therefore, identiﬁcation of a
subset of patients for whom radiotherapy is not necessary is
valuable [19].
It is controversial whether lateral pelvic lymph node metas-
tasis has a signiﬁcant role in the control of local recurrence. In
our study, two out of three local failures appeared to be caused
by lateral node metastasis. The incidence of lateral node metas-
tasis was 3.5% in this study, while it was estimated to be be-
tween 6.5% and 9.4% in a large series with 1,977 rectal
cancer patients [35], as well as in other studies [13,36], suggest-
ing a certain inﬂuence on local failure. So, due to our relatively
small number of patients, the real incidence of lateral node
metastasis and its role in determining prognosis cannot be
commented upon in this study.
We report a relatively overall high rate of continence
satisfaction of 95%, relatively higher than the reported in
other series of 90.8% [8], this can be explained by the fact that
most of our patients had partial ISR.
The authors report in this study, a 3-year survival and dis-
ease-free survival of 88.7% and 82.6%, respectively, matching
the other studies that reported 82–83% and 75–82%, respec-
tively [8,19].Conclusion
Intersphincteric resection with Total Mesorectal Resection
does not affect the local recurrence or overall survival rate.
In early rectal cancer T1-2, there is no need for radiation
therapy when meticulous dissection and stump irrigation are
applied. This technique provides bowel continuity, rendering
patients with no stoma with better quality of life.Conﬂict of interest
None.
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